Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Edwin Choy
A Man with Abdominal Pain, Foot Drop, and a Spinal Mass
In an NEJM Case Record, a 39-year-old man was admitted to the hospital with hypertension, abdominal pain, and foot drop. His blood pressure was 192/91 mm Hg on hospital admission. Imaging showed a hypervascular thoracic spinal mass with epidural extension causing cord compression. Serum and urine catecholamines were elevated, and biopsy showed a zellballen pattern (German for “ball of cells”; Figure 1).
A Man with Abdominal Pain, Foot Drop, and a Spinal Mass
Allan E. Pineda, M.D., Jad S. Husseini, M.D., Allan E. Pineda, M.D., Jad S. Husseini, M.D., Edwin Choy, M.D., Ph.D., Hugh G. Auchincloss, M.D., M.P.H., Ganesh M. Shankar, M.D., Ph.D., Frances J. Hayes, M.B., B.Ch. and Valentina Zanfagnin, M.D. New England Journal of Medicine Oct 14 Allan E. Pineda, M.D., Jad S. Husseini, M.D., Allan E. Pineda, M.D., Jad S. Husseini, M.D., Edwin Choy, M.D., Ph.D., Hugh G. Auchincloss, M.D., M.P.H., Ganesh M. Shankar, M.D., Ph.D., Frances J.
“Benign” Metastasizing Fibrous Histiocytoma Harboring PRKCD Gene Fusions With Malignant Clinical Course
Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request. References 1 WHO Classification of Tumours Editorial Board, WHO Classification of Tumours: Skin Tumours, 5th ed. (International Agency for Research on Cancer, 2023). 2, , and , “Cellular Benign Fibrous Histiocytoma.
Closing Thoughts, Future Perspectives, and Key Takeaways in the Treatment of Epithelioid Sarcoma
Summary for Physicians: Key Takeaways and Future Perspectives on ES Diagnosis and Treatment The diagnosis of ES requires a high level of clinical suspicion due to its rarity and varied presentation. Early recognition is crucial, and histopathologic examination combined with molecular testing (eg, INI1 loss) is essential for accurate diagnosis.
Expert Perspectives on the Assessment and Management of Advanced or Metastatic Epithelioid Sarcoma in the Second-Line Setting and Beyond
Summary for Physicians: Assessing and Managing Advanced or Metastatic ES for Subsequent Therapy When assessing patients with advanced or metastatic ES for second-line (2L) therapy, the evaluation of disease progression is guided by clinical assessment, imaging studies (eg, CT, MRI), and symptom monitoring. Disease progression is typically defined by radiographic evidence of new or enlarging lesions, clinical deterioration, or worsening symptoms.
Navigating Frontline Therapy in Epithelioid Sarcoma: Key Clinical Considerations and Shared Decision-Making
Summary for Physicians: Frontline Treatment Approach for ES The frontline treatment of ES typically involves a multimodal approach, incorporating surgery, radiation, and systemic therapy. The choice of therapy depends on tumor location, resectability, and disease stage. Role of Surgery and Radiation Therapy: Surgery is the mainstay for localized ES, with complete surgical resection being the preferred option for tumors that are amenable to this approach.
Managing Epithelioid Sarcoma: Follow-Up Strategies and Treatment Decisions for Stable Disease vs Progression
Summary for Physicians: Frontline Treatment Strategies for Advanced or Metastatic ES Role of Conventional Chemotherapy: Conventional chemotherapy remains a cornerstone in the treatment of advanced or metastatic ES, particularly in patients with aggressive disease or those who are not candidates for surgery or radiation. Common chemotherapy options include ifosfamide and gemcitabine, often used in combination to improve efficacy.
Management Strategies for Localized Epithelioid Sarcoma: The Role of Neoadjuvant and Adjuvant Therapies
Summary for Physicians: Management Strategies for Localized ES Neoadjuvant Therapy: For localized ES, neoadjuvant therapies may be considered in patients with large, resectable tumors or those at high risk for local recurrence. The goal of neoadjuvant therapy, which may include chemotherapy or radiation, is to shrink the tumor prior to surgical resection, making the tumor more amenable to complete surgical excision with clear margins.
A 62-Year-Old Woman With Epithelioid Sarcoma Treated With Tazemetostat
Summary for Physicians: Case-Based Discussion in ES A patient case was presented to illustrate the complexities of diagnosing and managing ES. The case highlighted the importance of early recognition, thorough diagnostic workup—including imaging and histopathologic evaluation—and the role of molecular testing (eg, INI1 loss) in confirming the diagnosis. Initial impressions from the group emphasized the diagnostic challenges, particularly when ES mimics benign or inflammatory conditions.
Navigating Diagnostic Challenges in Epithelioid Sarcoma: Multidisciplinary Strategies to Optimize Diagnosis
Summary for Physicians: Diagnostic Challenges and Pitfalls in ES Diagnosing ES is often challenging due to its rarity, variable presentation, and histologic overlap with other conditions. Common diagnostic pitfalls include misinterpreting ES as benign lesions such as granulomatous inflammation or reactive processes, especially in the early stages. The tumor’s epithelioid appearance may also lead to misclassification as carcinoma or other soft tissue sarcomas.
Confirming Epithelioid Sarcoma: Diagnostic Approach, Imaging, and Molecular Markers
Summary for Physicians: Diagnostic Approach to Suspected ES When evaluating a patient with suspected ES, a thorough diagnostic workup is essential to confirm the diagnosis and assess disease extent. Initial evaluation typically includes MRI of the primary site to define local anatomy and soft tissue involvement, along with CT imaging of the chest to evaluate for pulmonary metastases. PET/CT may be considered in selected cases for comprehensive staging.
Epithelioid Sarcoma: Histological Features and Differential Diagnoses
Summary for Physicians: Histological and Molecular Features of Epithelioid Sarcoma (ES) Epithelioid sarcoma (ES) typically presents with a painless, slow-growing mass, often in the distal extremities. The classic (distal) subtype is more common in younger patients and generally involves superficial soft tissues, whereas the proximal (large cell) subtype tends to affect older patients and arises in deeper tissues of the pelvis, perineum, or trunk.
Epithelioid Sarcoma: Overview and Presentation
Summary for Physicians: Epidemiology and Landscape of Epithelioid Sarcoma (ES) Epithelioid sarcoma (ES) is a rare, aggressive soft tissue sarcoma that primarily affects adolescents and young adults, with a slight male predominance. It most often arises in the distal extremities but can also occur in proximal areas, which may complicate diagnosis.
High‐Grade Uterine Sarcoma: First Report of a MEIS2::FOXO4 Fusion
Supporting Information Filename Description gcc70043-sup-0001-FigureS1.tifTIFF image, 1.1 MB Figure S1. (A) Fascicular architecture. (B) Small to medium-sized thin-walled vasculature. (C) Myxoid area with low-grade spindle cell morphology. (D) Epithelioid to spindled cells with moderate to marked cytologic atypia. gcc70043-sup-0002-FigureS2.tifTIFF image, 823.1 KB Figure S2. (A) No reactivity for desmin within tumor cells; entrapped normal myometrial cells are positive.
EWS-WT1 fusion isoforms establish oncogenic programs and therapeutic vulnerabilities in desmoplastic small round cell tumors - Nature Communications
Abstract EWS fusion oncoproteins underlie several human malignancies including Desmoplastic Small Round Cell Tumor (DSRCT), an aggressive cancer driven by EWS-WT1 fusion proteins. Here we combine chromatin occupancy and 3D profiles to identify EWS-WT1-dependent gene regulation networks and target genes. We show that EWS-WT1 is a powerful chromatin activator controlling an oncogenic gene expression program that characterizes primary tumors.
Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma
4 DISCUSSION The primary objectives of this study were to determine the objective response rate to palbociclib and ganitumab in patients with relapsed EWS and to determine the safety of giving this treatment combination. No patients met the RECIST definition of objective response. The combination therapy, which was based on palbociclib dosing established in patients with breast cancer, required dose reduction in this heavily pretreated population.
Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma - Nature Communications
Abstract There are more than 70 distinct sarcomas, and this diversity complicates the development of precision-based therapeutics for these cancers. Prospective comprehensive genomic profiling could overcome this challenge by providing insight into sarcomas’ molecular drivers. Through targeted panel sequencing of 7494 sarcomas representing 44 histologies, we identify highly recurrent and type-specific alterations that aid in diagnosis and treatment decisions.
A phase II multi-strata study of lurbinectedin as a single agent or in combination with conventional chemotherapy in metastatic and/or unresectable sarcomas
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Fig. 1 Waterfall and Swimmer plots are shown in 1A and 1B, respectively. Sarcoma histology is indicated by colour coding. There were seven partial responses and 1 patient with stable disease at 24 weeks in Stratum A. For stratum B, there was one partial response and two patients met the 24-week disease control end-point. Fig.
SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy
1. Daigeler A., Zmarsly I., Hirsch T., et al. Long-term outcome after local recurrence of soft tissue sarcoma: a retrospective analysis of factors predictive of survival in 135 patients with locally recurrent soft tissue sarcoma. British Journal of Cancer. 2014;110(6):1456–1464. doi: 10.1038/bjc.2014.21. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 2. Khalek Y., Vilor M., Sorrentino J., Brown M., Wills J., Herrera L.
Next‐Generation Sequencing for Patients with Sarcoma: A Single Center Experience
Disclosures of potential conflicts of interest may be found at the end of this article. Sarcomas comprise over 50 subtypes of mesenchymal cancers. For the majority of sarcomas, the driver mutations remain unknown. In this article, we describe our experience with a targeted next?generation sequencing (NGS) platform in clinic patients.
Therapeutic applications of histone deacetylase inhibitors in sarcoma
Publication HistoryPublished online: July 05, 2017Accepted: June 23, 2017; Received in revised form: June 21, 2017; Received: April 10, 2017;
Case 26-2016 - A 28-Year-Old Woman with Back Pain and a Lesion in the Lumbar Spine
A 28-year-old woman presented with intractable back pain with radiation to the leg. Examination of biopsy specimens revealed a giant-cell tumor of bone. Management decisions were made. This case was discussed at Cancer Center Grand Rounds. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.
PS-2Phase (ph) 3 study of eribulin (ERI) vs dacarbazine (DTIC) in leiomyosarcoma (LMS) and liposarcoma (LPS) patients (pts)
PS-2Phase (ph) 3 study of eribulin (ERI) vs dacarbazine (DTIC) in leiomyosarcoma (LMS) and liposarcoma (LPS) patients (pts) Patrick Schöffski1, Edwin Choy2, Axel Le Cesne3, Veridiana Camargo4, Sebastian Bauer5, Sun Young Rha6, Jean-Yves Blay7, David R D'Adamo8, Matthew Guo8 and Robert G Maki9 1Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium 2Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA 3Gustave Roussy, Villejuif,...
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Edwin
Contact Edwin, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack